Back to search

Article

Erythropoietin receptor is a risk factor for prognosis: a potential biomarker in lung adenocarcinoma

2022-02-24

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Lung cancer has the highest mortality rate of all cancers, and LUAD' s survival rate is particularly poor. Erythropoietin receptor (EPOR) can be detected in lung adenocarcinoma (LUAD), however, the expression levels and prognostic value of EPOR in LUAD are still unclear.<bold>Methods: </bold>Multiple bioinformatics databases, immunohistochemistry and clinicopath...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ed8cf8c7-4ef5-5bb7-9783-4e83315af1c1
DOI
10.21203/rs.3.rs-1211017/v3
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Erythropoietin receptor is a risk factor for prognosis: a potential biomarker in lung adenocarcinomaDOI 10.21203/rs.3.rs-1211017/v3
Select a neighboring publication to make it the new centre.